| Name | Deepverge Plc |
|---|---|
| Epic | DVRG |
| Isin | GB00BMGWZY29 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 0.15p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £0.56 | Debt ratio | n/a |
| Shares in issue | 372.79 | Debt-to-equity ratio | n/a |
| P/E ratio | 18.7 | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -31.51 |
| Dividend cover | n/a | EPS growth | -38 |
| Earning per share | 1.3 | 52-week high / low | 0.15p / 16.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Deepverge Plc |
|---|---|
| Address | York Biotech Campus, Sand Hutton, York, North Yorkshire, United Kingdom, YO41 1LZ |
| Telephone | +44 (0) 1904 40 4036 |
| Website | http://www.deepverge.com/ |
| Director | Position |
|---|---|
| Mr Ross Andrews | Non-Executive Chairman |
| Mr Nigel Burton | Interim CEO |
| Assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Reporting date | 31/12/21 | 31/12/20 | 31/12/19 |
| Intangible asssets and goodwill | 18.13 | 18.24 | 3.65 |
| Investments and other non-current assets | 0.35 | 0.35 | 0.71 |
| Total non-current assets | 20.96 | 20.04 | 5.34 |
| Inventory / work in progress | 1.71 | 1.35 | 0.09 |
| Trade and other receivables | 6.79 | 1.45 | 0.55 |
| Cash and equivalents | 1.85 | 1.44 | 1.19 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 31.3 | 24.27 | 7.16 |
| Liabilities £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Short term liabilities | 3.91 | 4.61 | 1.04 |
| Long term liabilities | 3.63 | 3.74 | 1.04 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 7.54 | 8.35 | 2.08 |
| Net assets £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Net assets | 23.76 | 15.92 | 5.09 |
| Equity £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Share capital | 2.43 | 2.38 | 2.32 |
| Minority interests | n/a | 0.79 | n/a |
| Retained earnings | -20.74 | -18.96 | -15.4 |
| Share premium account | 36.89 | 25.07 | 11.74 |
| Total equity | 23.76 | 15.92 | 5.09 |
| Income £ (m) | 2021 | 2020 | 2019 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -3.26 | 2.72 | -2.37 |
| Pre-tax profit | -3.68 | -2.9 | -2.4 |